CERTOLIZUMAB: 531 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
531
Total FAERS Reports
32 (6.0%)
Deaths Reported
164
Hospitalizations
531
As Primary/Secondary Suspect
28
Life-Threatening
25
Disabilities
First Report: 20050901 · Latest Report: 20240919
What Are the Most Common CERTOLIZUMAB Side Effects?
#1 Most Reported
Drug ineffective
156 reports (29.4%)
#2 Most Reported
Infection
71 reports (13.4%)
#3 Most Reported
Off label use
64 reports (12.1%)
All CERTOLIZUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 156 | 29.4% | 5 | 48 |
| Infection | 71 | 13.4% | 8 | 35 |
| Off label use | 64 | 12.1% | 3 | 16 |
| Rheumatoid arthritis | 53 | 10.0% | 2 | 19 |
| Drug intolerance | 51 | 9.6% | 2 | 16 |
| Arthritis | 44 | 8.3% | 0 | 26 |
| Therapeutic product effect decreased | 39 | 7.3% | 1 | 20 |
| Condition aggravated | 36 | 6.8% | 2 | 11 |
| Treatment failure | 36 | 6.8% | 1 | 6 |
| Pneumonia | 35 | 6.6% | 5 | 24 |
| Psoriasis | 35 | 6.6% | 0 | 11 |
| Rash | 34 | 6.4% | 7 | 11 |
| Sinusitis | 33 | 6.2% | 6 | 10 |
| Crohn's disease | 31 | 5.8% | 0 | 5 |
| Maternal exposure during pregnancy | 29 | 5.5% | 2 | 10 |
| Nausea | 29 | 5.5% | 0 | 5 |
| Psoriatic arthropathy | 29 | 5.5% | 2 | 12 |
| Therapeutic product effect incomplete | 29 | 5.5% | 0 | 8 |
| Headache | 25 | 4.7% | 6 | 7 |
| Arthralgia | 24 | 4.5% | 2 | 11 |
Who Reports CERTOLIZUMAB Side Effects? Age & Gender Data
Gender: 74.8% female, 25.2% male. Average age: 54.0 years. Most reports from: US. View detailed demographics →
Is CERTOLIZUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 10 | 0 | 9 |
| 2009 | 1 | 0 | 0 |
| 2010 | 8 | 0 | 7 |
| 2011 | 1 | 0 | 0 |
| 2012 | 6 | 0 | 4 |
| 2013 | 14 | 0 | 6 |
| 2014 | 17 | 1 | 7 |
| 2015 | 2 | 0 | 1 |
| 2016 | 9 | 0 | 8 |
| 2017 | 22 | 0 | 5 |
| 2018 | 12 | 0 | 7 |
| 2019 | 16 | 0 | 1 |
| 2020 | 7 | 0 | 3 |
| 2021 | 6 | 1 | 2 |
| 2022 | 11 | 0 | 7 |
| 2023 | 5 | 0 | 3 |
| 2024 | 2 | 0 | 0 |
What Is CERTOLIZUMAB Used For?
| Indication | Reports |
|---|---|
| Rheumatoid arthritis | 158 |
| Product used for unknown indication | 137 |
| Crohn's disease | 62 |
| Psoriatic arthropathy | 45 |
| Ankylosing spondylitis | 28 |
| Inflammatory bowel disease | 19 |
| Psoriasis | 19 |
| Juvenile idiopathic arthritis | 16 |
| Malignant melanoma | 10 |
| Arthritis | 9 |
CERTOLIZUMAB vs Alternatives: Which Is Safer?
CERTOLIZUMAB vs CERTOLIZUMAB PEGOL
CERTOLIZUMAB vs CERTOPARIN
CERTOLIZUMAB vs CETIRIZINE
CERTOLIZUMAB vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB vs CETRIMIDE
CERTOLIZUMAB vs CETRORELIX
CERTOLIZUMAB vs CETUXIMAB
CERTOLIZUMAB vs CETYLPYRIDINIUM
CERTOLIZUMAB vs CEVIMELINE
CERTOLIZUMAB vs CHAMPIX
Official FDA Label for CERTOLIZUMAB
Official prescribing information from the FDA-approved drug label.